Nick Bansback


Research Scientist, Health Economics, MSc, PhD



  • Associate Professor, School of Population and Public Health,
    University of British Columbia
  • Scientist, Centre for Advancing Health Outcomes,
    Providence Health Research Institute


Research Interests

  • Health Economics
  • Cost-effectiveness of biologics in the treatment of rheumatoid arthritis
  • How patients and physicians make decisions


Dr. Nick Bansback has a BSc in Mathematics, a MSc in Health Services Research, and a PhD in Health Economics. He has authored over 60 papers and more than 100 research abstracts.

Learn more

Dr. Bansback’s research aims to inform policies and practices in health through the application of decision theory. Much of his work to date has focused on informing resource allocation policy decisions through measuring and valuing public preferences, and developing decision-analytic models. His research of the cost-effectiveness of biologics in the treatment of rheumatoid arthritis has informed policy in numerous countries. An emerging area of research seeks to improve decision making at the patient/physician consultation using novel decision support tools based on behavioral economic theory.


Arthritis Publications


Trenaman L, Stacey D, Bryan S, Taljaard M, Hawker G, Dervin G, Tugwell P,Bansback N. Decision aids for patients considering total joint replacement: A cost-effectiveness analysis alongside a randomised controlled trial. Osteoarthritis Cartilage. 2017 Jun 14. pii: S1063-4584(17)31042-7. doi: 10.1016/j.joca.2017.05.022. [Epub ahead of print] PubMed PMID: 28624294. https://www.ncbi.nlm.nih.gov/pubmed/28624294


Bansback N, Phibbs CS, Sun H, O’Dell JR, Brophy M, Keystone EC, Leatherman S,  Mikuls TR, Anis AH; CSP 551 RACAT Investigators. Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis. Ann Intern Med. 2017 May 30. doi: 10.7326/M16-0713. [Epub ahead of print] PubMed PMID: 28554192. https://www.ncbi.nlm.nih.gov/pubmed/28554192


Li LC, Shaw C, Lacaille D, Yacyshyn E, Jones CA, Koehn C, Hoens AM, Geldman J, Sayre EC, Macdonald G, Leese J, Bansback N. Effects of a Web-Based Patient Decision Aid on Biologic and Small Molecule Agents for Rheumatoid Arthritis, ANSWER-2: A Proof-of-Concept Study. Arthritis Care Res (Hoboken). 2017 May 23. doi: 10.1002/acr.23287. [Epub ahead of print] PubMed PMID: 28544648. https://www.ncbi.nlm.nih.gov/pubmed/28544648


Harrison M, Milbers K, Hudson M, Bansback N. Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open. 2017 May 17;7(5):e014719. doi: 10.1136/bmjopen-2016-014719. PubMed PMID: 28515194. https://www.ncbi.nlm.nih.gov/pubmed/28515194


Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C, Taylor W, Barton J, Tugwell P, Wells G, Bansback N. OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?  J Rheumatol. 2017 Mar 15. pii: jrheum.161112. doi: 10.3899/jrheum.161112. [Epub ahead of print] PubMed PMID: 28298567. https://www.ncbi.nlm.nih.gov/pubmed/28298567


Osterhoff G, O’Hara NN, D’Cruz J, Sprague SA, Bansback N, Evaniew N, Slobogean GP. A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the  Elderly. Value Health. 2017 Mar;20(3):404-411. doi: 10.1016/j.jval.2016.10.017. Epub 2016 Dec 12. PubMed PMID: 28292485. https://www.ncbi.nlm.nih.gov/pubmed/28292485


Trenaman L, Bansback N. Moving from outcomes to values to deliver high-quality health care-A new checklist for valuation studies. J Clin Epidemiol. 2017 Mar;83:3-5. doi: 10.1016/j.jclinepi.2016.11.020. Epub 2017 Jan 17. PubMed PMID: 28104463. https://www.ncbi.nlm.nih.gov/pubmed/28104463


Bansback N, Bell M, Spooner L, Pompeo A, Han PKJ, Harrison M. Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions. Patient. 2017 Jun;10(3):311-319. doi: 10.1007/s40271-016-0210-z. PubMed PMID: 27905072. https://www.ncbi.nlm.nih.gov/pubmed/27905072


Kanters S, Ford N, Druyts E, Thorlund K, Mills EJ, Bansback N. Use of network meta-analysis in clinical guidelines. Bull World Health Organ. 2016 Oct 1;94(10):782-784. Epub 2016 Aug 30. PubMed PMID: 27843171; PubMed Central PMCID:  PMC5043215. https://www.ncbi.nlm.nih.gov/pubmed/27843171


Yazdany J, Bansback N, Clowse M, Collier D, Law K, Liao KP, Michaud K, Morgan EM, Oates JC, Orozco C, Reimold A, Simard JF, Myslinski R, Kazi S. Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1866-1873. doi: 10.1002/acr.23089. PubMed PMID: 27696755; PubMed Central PMCID: PMC5125872. https://www.ncbi.nlm.nih.gov/pubmed/27696755


Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH. Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study. RMD Open. 2016 Jul 7;2(2):e000222. doi:  10.1136/rmdopen-2015-000222. eCollection 2016. PubMed PMID: 27486524; PubMed Central PMCID: PMC4947791. https://www.ncbi.nlm.nih.gov/pubmed/27486524


Finckh A, Escher M, Liang MH, Bansback N. Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences. Curr Rheumatol Rep. 2016 Aug;18(8):51. doi: 10.1007/s11926-016-0598-4. Review. PubMed PMID: 27402108. https://www.ncbi.nlm.nih.gov/pubmed/27402108


Bansback N, Harrison M, Sadatsafavi M, Stiggelbout A, Whitehurst DG. Attitude to health risk in the Canadian population: a cross-sectional survey. CMAJ Open. 2016 Jun 3;4(2):E284-91. doi: 10.9778/cmajo.20150071. eCollection 2016 Apr-Jun. PubMed PMID: 27398375; PubMed Central PMCID: PMC4933649. https://www.ncbi.nlm.nih.gov/pubmed/27398375


Bansback N, Shojania K, Lacaille D. Improving patient-centred care for rheumatoid arthritis. CMAJ. 2016 Oct 4;188(14):999-1000. Epub 2016 Jun 27. PubMed PMID: 27354676; PubMed Central PMCID: PMC5047811. https://www.ncbi.nlm.nih.gov/pubmed/27354676


Trenaman L, Selva A, Desroches S, Singh K, Bissonnette J, Bansback N, Stacey  D. A measurement framework for adherence in patient decision aid trials applied in a systematic review subanalysis. J Clin Epidemiol. 2016 Sep;77:15-23. doi: 10.1016/j.jclinepi.2016.03.032. Epub 2016 May 13. Review. PubMed PMID: 27185074. https://www.ncbi.nlm.nih.gov/pubmed/27185074


Harrison M, Marra CA, Bansback N. Preferences for ‘New’ Treatments Diminish in the Face of Ambiguity. Health Econ. 2017 Jun;26(6):743-752. doi: 10.1002/hec.3353. Epub 2016 May 12. PubMed PMID: 27174417. https://www.ncbi.nlm.nih.gov/pubmed/27174417


Harvard S, Guh D, Bansback N, Richette P, Dougados M, Anis A, Fautrel B. Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort. RMD Open. 2016 Apr 4;2(1):e000230. doi: 10.1136/rmdopen-2015-000230. eCollection 2016. PubMed PMID: 27099778; PubMed Central PMCID: PMC4823587. https://www.ncbi.nlm.nih.gov/pubmed/27099778


Bansback N, Keystone E, O’Dell J, Phibbs CS, Hannagan K, Brophy M, Anis A. Making smart investment decisions in clinical research. Trials. 2015 Dec 29;16:590. doi: 10.1186/s13063-015-1123-1. PubMed PMID: 26712327; PubMed Central  PMCID: PMC4693420. https://www.ncbi.nlm.nih.gov/pubmed/26712327


Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review. Patient Educ Couns. 2016 Apr;99(4):491-500. doi: 10.1016/j.pec.2015.10.026. Epub 2015 Nov 2. Review. PubMed PMID: 26549169. https://www.ncbi.nlm.nih.gov/pubmed/26549169


Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH. Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study. RMD Open. 2015 Apr 8;1(1):e000042. doi: 10.1136/rmdopen-2014-000042. eCollection 2015. PubMed PMID: 26535135; PubMed Central PMCID: PMC4613161. https://www.ncbi.nlm.nih.gov/pubmed/26535135


Bansback N, Harrison M, Marra C. Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments? Med Decis Making. 2016 May;36(4):490-502. doi: 10.1177/0272989X15600708. Epub 2015 Aug 24. PubMed PMID: 26304064. https://www.ncbi.nlm.nih.gov/pubmed/26304064


Trenaman L, Bryan S, Bansback N. The cost-effectiveness of patient decision aids: A systematic review. Healthc (Amst). 2014 Dec;2(4):251-7. doi: 10.1016/j.hjdsi.2014.09.002. Epub 2014 Oct 3. Review. PubMed PMID: 26250632. https://www.ncbi.nlm.nih.gov/pubmed/26250632


Pollard S, Bansback N, Bryan S. Physician attitudes toward shared decision making: A systematic review. Patient Educ Couns. 2015 Sep;98(9):1046-57. doi: 10.1016/j.pec.2015.05.004. Epub 2015 May 23. Review. PubMed PMID: 26138158. https://www.ncbi.nlm.nih.gov/pubmed/26138158


Harrison M, Marra C, Shojania K, Bansback N. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment. Rheumatology (Oxford). 2015 Oct;54(10):1816-25. doi: 10.1093/rheumatology/kev113. Epub 2015 May 18. PubMed PMID: 25989956. https://www.ncbi.nlm.nih.gov/pubmed/25989956


Bansback N, Trenaman L, Harrison M. How important is mode of administration in treatments for rheumatic diseases and related conditions? Curr Rheumatol Rep.  2015 Jun;17(6):514. doi: 10.1007/s11926-015-0514-3. Review. PubMed PMID: 25903666. https://www.ncbi.nlm.nih.gov/pubmed/25903666


Crump T, Wing K, Bansback N, Sutherland JM. Surgical assessment: measuring unobserved health. BMC Surg. 2015 Jan 15;15:4. doi: 10.1186/1471-2482-15-4. PubMed PMID: 25591412; PubMed Central PMCID: PMC4324857. https://www.ncbi.nlm.nih.gov/pubmed/25591412